Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observer-blind, Dose Ranging Safety and Immunogenicity Study of GSK Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age

NCT02719743 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02719743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02719743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observer-blind, Dose Ranging Safety and Immunogenicity Study of GSK Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
July 7, 2016
Completion date
February 13, 2018
Enrollment
185 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

influenza